437 related articles for article (PubMed ID: 25636338)
21. Plasmablastic Lymphoma: Past, Present, and Future.
Kaur S; Kollimuttathuillam S
Clin Lymphoma Myeloma Leuk; 2023 Sep; 23(9):e253-e259. PubMed ID: 37453866
[TBL] [Abstract][Full Text] [Related]
22. Bortezomib, Lenalidomide and Dexamethasone Combination Induced Complete Remission in Relapsed/Refractory Plasmablastic Lymphoma: Case Report of a Potential Novel Treatment Approach.
Sabry W; Wu Y; Kodad SG
Curr Oncol; 2022 Jul; 29(7):5042-5053. PubMed ID: 35877259
[TBL] [Abstract][Full Text] [Related]
23. Survival of patients with CD20-negative variants of large B-cell lymphoma: an analysis of the National Cancer Data Base.
Qunaj L; Castillo JJ; Olszewski AJ
Leuk Lymphoma; 2018 Jun; 59(6):1375-1383. PubMed ID: 29019447
[TBL] [Abstract][Full Text] [Related]
24. HIV-related plasmablastic lymphoma causing extensive bone destruction in the mandible.
Kayahara GM; Valente VB; Salzedas LMP; Passador-Santos F; Furuse C; Biasoli ÉR; Miyahara GI; Bernabé DG
Oral Oncol; 2022 Mar; 126():105761. PubMed ID: 35151011
[TBL] [Abstract][Full Text] [Related]
25. Clinical characteristics and prognostic factors of plasmablastic lymphoma patients: analysis of 135 patients from the LYSA group.
Tchernonog E; Faurie P; Coppo P; Monjanel H; Bonnet A; Algarte Génin M; Mercier M; Dupuis J; Bijou F; Herbaux C; Delmer A; Fabiani B; Besson C; Le Gouill S; Gyan E; Laurent C; Ghesquieres H; Cartron G
Ann Oncol; 2017 Apr; 28(4):843-848. PubMed ID: 28031174
[TBL] [Abstract][Full Text] [Related]
26. Diffuse large B-cell lymphomas with plasmablastic differentiation.
Teruya-Feldstein J
Curr Oncol Rep; 2005 Sep; 7(5):357-63. PubMed ID: 16091196
[TBL] [Abstract][Full Text] [Related]
27. Clinical, pathological and molecular features of plasmablastic lymphoma arising in the gastrointestinal tract: A review and reappraisal.
Sanguedolce F; Zanelli M; Zizzo M; Martino G; Rossi C; Parente P; Ascani S
Pathol Res Pract; 2020 Jun; 216(6):152973. PubMed ID: 32370987
[TBL] [Abstract][Full Text] [Related]
28. CD3-positive plasmablastic lymphoma reported in two cases: A potential diagnostic caveat.
Wong YP; Masir N; Chew MX
Indian J Pathol Microbiol; 2021; 64(3):579-583. PubMed ID: 34341278
[TBL] [Abstract][Full Text] [Related]
29. De Novo Unclassifiable CD20-Negative Diffuse Large B-Cell Lymphoma: A Diagnostic and Therapeutic Challenge.
AbdullGaffar B; Seliem RM
Int J Surg Pathol; 2018 May; 26(3):266-270. PubMed ID: 28982264
[TBL] [Abstract][Full Text] [Related]
30. CD20-negative large-cell lymphoma with plasmablastic features: a clinically heterogenous spectrum in both HIV-positive and -negative patients.
Teruya-Feldstein J; Chiao E; Filippa DA; Lin O; Comenzo R; Coleman M; Portlock C; Noy A
Ann Oncol; 2004 Nov; 15(11):1673-9. PubMed ID: 15520070
[TBL] [Abstract][Full Text] [Related]
31. [Long-term complete remission of HIV-negative primary testicular plasmablastic lymphoma treated with bortezomib in combination with EPOCH].
Fujishima T; Kawabata Y; Michishita Y; Kitabayashi A; Takahashi N
Rinsho Ketsueki; 2022; 63(10):1386-1391. PubMed ID: 36351644
[TBL] [Abstract][Full Text] [Related]
32. Plasmablastic lymphoma of the oral cavity in an HIV-positive patient: staging with 18F-FDG PET/CT.
Makis W; Ciarallo A; Lisbona R
Acta Radiol; 2011 Nov; 52(9):970-2. PubMed ID: 21911839
[TBL] [Abstract][Full Text] [Related]
33. Oral cavity and extra-oral plasmablastic lymphomas in AIDS patients: report of five cases and review of the literature.
Corti M; Villafañe MF; Bistmans A; Campitelli A; Narbaitz M; Baré P
Int J STD AIDS; 2011 Dec; 22(12):759-63. PubMed ID: 22174064
[TBL] [Abstract][Full Text] [Related]
34. Plasmablastic haemato-lymphoid neoplasm with a complex genetic signature of Burkitt lymphoma responding to bortezomib.
Dasanu CA; Bauer F; Codreanu I; Padmanabhan P; Rampurwala M
Hematol Oncol; 2013 Sep; 31(3):164-6. PubMed ID: 22899491
[TBL] [Abstract][Full Text] [Related]
35. Cutaneous plasmablastic lymphoma.
Jambusaria A; Shafer D; Wu H; Al-Saleem T; Perlis C
J Am Acad Dermatol; 2008 Apr; 58(4):676-8. PubMed ID: 18342714
[TBL] [Abstract][Full Text] [Related]
36. Plasmablastic Lymphoma Involving Kidney in an HIV Positive Patient: A Case Report with Review of the Literature.
Sapkota S; Priyadarshini M; Hazarika D; Swamy S; Naik R
Indian J Nephrol; 2021; 31(2):176-178. PubMed ID: 34267442
[TBL] [Abstract][Full Text] [Related]
37. Clinicopathologic comparison of plasmablastic lymphoma in HIV-positive, immunocompetent, and posttransplant patients: single-center series of 25 cases and meta-analysis of 277 reported cases.
Morscio J; Dierickx D; Nijs J; Verhoef G; Bittoun E; Vanoeteren X; Wlodarska I; Sagaert X; Tousseyn T
Am J Surg Pathol; 2014 Jul; 38(7):875-86. PubMed ID: 24832164
[TBL] [Abstract][Full Text] [Related]
38. Plasmablastic lymphoma of the gastrointestinal tract: A rare entity with a dismal prognosis.
Komaranchath AS; Haleshappa RA; Kuntegowdenahalli LC; Kumar RV; Dasappa L; Babu G
Indian J Cancer; 2016; 53(4):529-533. PubMed ID: 28485344
[TBL] [Abstract][Full Text] [Related]
39. Clinicopathologic features and abnormal signaling pathways in plasmablastic lymphoma: a multicenter study in China.
Shi D; Gao L; Wan XC; Li J; Tian T; Hu J; Zhang QL; Su YF; Zeng YP; Hu ZJ; Yu BH; Li XQ; Wei P; Li JW; Zhou XY
BMC Med; 2022 Dec; 20(1):483. PubMed ID: 36522654
[TBL] [Abstract][Full Text] [Related]
40. CD20-negative diffuse large B cell lymphoma: a comprehensive analysis of 695 cases.
Li J; Zhao S; Wang J; Chen J; Wen W; Zhang Q
Tumour Biol; 2016 Mar; 37(3):3619-37. PubMed ID: 26459310
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
